99 related articles for article (PubMed ID: 21050068)
1. A quantitative assay for lysosomal acidification rates in human osteoclasts.
Jensen VK; Nosjean O; Dziegiel MH; Boutin JA; Sørensen MG; Karsdal MA; Henriksen K
Assay Drug Dev Technol; 2011 Apr; 9(2):157-64. PubMed ID: 21050068
[TBL] [Abstract][Full Text] [Related]
2. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption.
Sørensen MG; Henriksen K; Neutzsky-Wulff AV; Dziegiel MH; Karsdal MA
J Bone Miner Res; 2007 Oct; 22(10):1640-8. PubMed ID: 17576165
[TBL] [Abstract][Full Text] [Related]
3. Ion transporters involved in acidification of the resorption lacuna in osteoclasts.
Henriksen K; Sørensen MG; Jensen VK; Dziegiel MH; Nosjean O; Karsdal MA
Calcif Tissue Int; 2008 Sep; 83(3):230-42. PubMed ID: 18787885
[TBL] [Abstract][Full Text] [Related]
4. Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7.
Henriksen K; Gram J; Neutzsky-Wulff AV; Jensen VK; Dziegiel MH; Bollerslev J; Karsdal MA
Biochem Biophys Res Commun; 2009 Jan; 378(4):804-9. PubMed ID: 19070589
[TBL] [Abstract][Full Text] [Related]
5. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
6. Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.
Sørensen MG; Karsdal MA; Dziegiel MH; Boutin JA; Nosjean O; Henriksen K
BMC Musculoskelet Disord; 2010 Oct; 11():250. PubMed ID: 20977756
[TBL] [Abstract][Full Text] [Related]
7. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation.
Schaller S; Henriksen K; Sveigaard C; Heegaard AM; Hélix N; Stahlhut M; Ovejero MC; Johansen JV; Solberg H; Andersen TL; Hougaard D; Berryman M; Shiødt CB; Sørensen BH; Lichtenberg J; Christophersen P; Foged NT; Delaissé JM; Engsig MT; Karsdal MA
J Bone Miner Res; 2004 Jul; 19(7):1144-53. PubMed ID: 15176998
[TBL] [Abstract][Full Text] [Related]
8. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
Karsdal MA; Henriksen K; Sørensen MG; Gram J; Schaller S; Dziegiel MH; Heegaard AM; Christophersen P; Martin TJ; Christiansen C; Bollerslev J
Am J Pathol; 2005 Feb; 166(2):467-76. PubMed ID: 15681830
[TBL] [Abstract][Full Text] [Related]
9. Expression of mouse osteoclast K-Cl Co-transporter-1 and its role during bone resorption.
Kajiya H; Okamoto F; Li JP; Nakao A; Okabe K
J Bone Miner Res; 2006 Jul; 21(7):984-92. PubMed ID: 16813519
[TBL] [Abstract][Full Text] [Related]
10. Visualization of acidic compartments in cultured osteoclasts by use of an acidotrophic amine as a marker for low pH.
Inoue M; Yoshida H; Akisaka T
Cell Tissue Res; 1999 Dec; 298(3):527-37. PubMed ID: 10639743
[TBL] [Abstract][Full Text] [Related]
11. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
Niikura K; Takano M; Sawada M
Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the osteoclast ruffled border chloride channel and its role in bone resorption.
Schlesinger PH; Blair HC; Teitelbaum SL; Edwards JC
J Biol Chem; 1997 Jul; 272(30):18636-43. PubMed ID: 9228032
[TBL] [Abstract][Full Text] [Related]
13. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts.
Sahara T; Itoh K; Debari K; Sasaki T
Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690
[TBL] [Abstract][Full Text] [Related]
14. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment.
Schaller S; Henriksen K; Sørensen MG; Karsdal MA
Drug News Perspect; 2005 Oct; 18(8):489-95. PubMed ID: 16391718
[TBL] [Abstract][Full Text] [Related]
15. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
[TBL] [Abstract][Full Text] [Related]
16. A mathematical model of osteoclast acidification during bone resorption.
Marcoline FV; Ishida Y; Mindell JA; Nayak S; Grabe M
Bone; 2016 Dec; 93():167-180. PubMed ID: 27650914
[TBL] [Abstract][Full Text] [Related]
17. c-Src control of chloride channel support for osteoclast HCl transport and bone resorption.
Edwards JC; Cohen C; Xu W; Schlesinger PH
J Biol Chem; 2006 Sep; 281(38):28011-22. PubMed ID: 16831863
[TBL] [Abstract][Full Text] [Related]
18. Osteoclastic acidification pathways during bone resorption.
Rousselle AV; Heymann D
Bone; 2002 Apr; 30(4):533-40. PubMed ID: 11934642
[TBL] [Abstract][Full Text] [Related]
19. Passive chloride permeability charge coupled to H(+)-ATPase of avian osteoclast ruffled membrane.
Blair HC; Teitelbaum SL; Tan HL; Koziol CM; Schlesinger PH
Am J Physiol; 1991 Jun; 260(6 Pt 1):C1315-24. PubMed ID: 1829326
[TBL] [Abstract][Full Text] [Related]
20. A difference in the enzyme contents of resorption lacunae and secondary lysosomes of osteoclasts.
Karhukorpi EK; Vihko P; Väänänen K
Acta Histochem; 1992; 92(1):1-11. PubMed ID: 1580139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
